Literature DB >> 24639406

A novel KCNA1 mutation causing episodic ataxia type I.

Saskia Lassche1, Sergio Lainez, Bastiaan R Bloem, Bart P C van de Warrenburg, Jeannette Hofmeijer, Henny H Lemmink, Joost G J Hoenderop, René J M Bindels, Gea Drost.   

Abstract

We describe the clinical phenotype of a novel de novo KNCA1 mutation, and functional characterization of the effects of the mutation on Kv1.1 channel function. HEK293 cells were transfected transiently with either wild-type or mutant channels. Representative currents were evoked after application of a series of square voltage steps from -80 mV to +50 mV in 200-ms intervals from Vh = -80 mV. Extracellular K(+) was added to evoke tail currents. Equal amounts of wild-type and Kv1.1(I262M) mutant DNA were transfected transiently in HEK293 cells to evaluate the influence of the mutation. We found that Kv1.1(I262M) leads to a defective voltage-gated potassium channel. Coexpression studies revealed a dominant-negative effect. We describe the phenotype of a novel KCNA1 mutation causing episodic ataxia. Patch-clamp studies confirm the pathogenicity of the mutation in vitro and suggest that it is dominant with respect to wild-type.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  KCNA1; channelopathy; episodic ataxia type 1; ion channels; potassium channel

Mesh:

Substances:

Year:  2014        PMID: 24639406     DOI: 10.1002/mus.24242

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.

Authors:  Catherine A Brownstein; Alan H Beggs; Lance Rodan; Jiahai Shi; Meghan C Towne; Renee Pelletier; Siqi Cao; Paul A Rosenberg; David K Urion; Jonathan Picker; Wen-Hann Tan; Pankaj B Agrawal
Journal:  Neurogenetics       Date:  2015-09-22       Impact factor: 2.660

2.  Auditory deficits of Kcna1 deletion are similar to those of a monaural hearing impairment.

Authors:  Anita Karcz; Paul D Allen; Joseph Walton; James R Ison; Cornelia Kopp-Scheinpflug
Journal:  Hear Res       Date:  2015-01-17       Impact factor: 3.208

Review 3.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

4.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

5.  Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.

Authors:  Haiming Yuan; Huihua Yuan; Qingming Wang; Wanhua Ye; Ruixia Yao; Wanfang Xu; Yanhui Liu
Journal:  Mol Genet Genomic Med       Date:  2020-07-23       Impact factor: 2.183

6.  A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.

Authors:  Juan Zhao; Dimitri Petitjean; Georges A Haddad; Zarah Batulan; Rikard Blunck
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

Review 7.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

8.  Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I.

Authors:  Zeynep S Karalok; Alfredo Megaro; Marta Cenciarini; Alev Guven; Sonia M Hasan; Birce D Taskin; Paola Imbrici; Serdar Ceylaner; Mauro Pessia; Maria C D'Adamo
Journal:  Front Neurol       Date:  2018-07-25       Impact factor: 4.003

Review 9.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.